Alchemee LLC

Who owns Alchemee?
Alchemee is wholly owned by Taro Pharmaceutical Industries, an Israeli-American pharmaceutical company. Taro became a wholly owned subsidiary of Sun Pharmaceutical Industries of India in 2024. Before 2022, Alchemee was owned by Galderma.

What happened to The Proactiv Company?
The Proactiv Company was renamed Alchemee in 2020 to reflect plans to become a multi-brand skincare company. In February 2022, Galderma sold Alchemee, including the Proactiv brand, to Taro Pharmaceutical Industries.

Who founded Proactiv?
Proactiv was created in 1995 by dermatologists Katie Rodan and Kathy Fields. The same doctors later founded Rodan + Fields, a separate skincare company. Proactiv was originally marketed in partnership with direct-response company Guthy-Renker.

Where is Alchemee headquartered?
Alchemee is headquartered in Santa Monica, California, at 120 Broadway. The office has experienced workforce reductions, including 89 layoffs disclosed in California WARN notices.

Does Alchemee own any brands other than Proactiv?
Yes. Alchemee's portfolio includes Restorative Elements, a repair-focused skincare line, and In Defense of Skin, a newer brand announced on its website. Proactiv remains the flagship and the source of most revenue.

Proactiv was created in 1995 by dermatologists Katie Rodan and Kathy Fields, who developed a multi-step acne regimen they could sell directly to patients. They partnered with Guthy-Renker, the Palm Desert, California direct marketing company known for celebrity-driven infomercials. The combination of a credible dermatological product and aggressive direct-response television advertising made Proactiv one of the most successful infomercial products in history.

Through the late 1990s and 2000s, Proactiv infomercials featuring celebrities including Jessica Simpson, Alicia Keys, Kendall Jenner, and Justin Bieber made the brand a fixture of American television. The subscription model generated recurring revenue and high margins. At its peak, Proactiv generated annual revenue estimated near $1 billion.

In 2016, Nestlé Skin Health, the skin health unit Nestlé had assembled through its 2014 acquisition of full control of Galderma, took over the Proactiv business from Guthy-Renker. When Nestlé sold Nestlé Skin Health to a private equity consortium led by EQT in 2019, the unit was renamed Galderma, and the Proactiv business became The Proactiv Company within Galderma's consumer portfolio.

The business was rebranded as Alchemee in 2020, signaling an ambition to build a multi-brand skincare portfolio beyond Proactiv. In February 2022, Galderma sold Alchemee to Taro Pharmaceutical Industries, an Israeli-American generic and specialty pharmaceutical company seeking to expand in over-the-counter dermatology. Financial terms were not disclosed. The acquisition closed on February 28, 2022.

In 2024, Sun Pharmaceutical Industries of India completed its acquisition of the remaining shares of Taro, making Taro a wholly owned subsidiary. Alchemee thereby became part of Sun Pharma's global dermatology business, which also includes Taro's prescription dermatology products.

Alchemee does not hold independent sustainability certifications such as Leaping Bunny, PETA cruelty-free certification, or B Corp status. Proactiv products contain pharmaceutical active ingredients regulated by the FDA as over-the-counter drugs, and the brand does not market itself on natural or clean beauty positioning.

Parent company Taro manufactures in facilities regulated by the FDA and international equivalents, and Sun Pharma publishes group-level ESG disclosures covering environmental targets and access-to-medicine programs.

Subscription billing complaints: Proactiv's auto-renewing subscription model generated years of consumer complaints about unexpected charges and difficulty canceling. The Federal Trade Commission has taken action against negative-option subscription practices across the industry, and Guthy-Renker settled a California civil case in the 2000s over automatic renewal disclosures. Proactiv has since updated its checkout disclosures.

Animal testing historical status: Proactiv historically did not qualify as cruelty-free because its products were sold in markets requiring animal testing. This status has been a recurring point of criticism from animal welfare organizations.

Ownership under Sun Pharma: Parent company Sun Pharma has faced regulatory actions at its manufacturing facilities, including FDA warning letters and import alerts at certain Indian plants in the 2020s. These actions concern Sun Pharma facilities broadly rather than Alchemee products specifically.